PP
GILD icon

PDS Planning’s Gilead Sciences GILD Stock Holding History

PDS Planning’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$850K Buy
6,101
+169
+3% +$23.7K 0.06% 168
2025
Q4 		$728K Buy
5,932
+18
+0.3% +$2.19K 0.05% 188
2025
Q3 		$656K Buy
5,914
+124
+2% +$14.1K 0.05% 197
2025
Q2 		$642K Buy
5,790
+592
+11% +$63K 0.05% 194
2025
Q1 		$582K Buy
5,198
+528
+11% +$54.5K 0.05% 189
2024
Q4 		$431K Buy
4,670
+170
+4% +$15.3K 0.04% 216
2024
Q3 		$377K Buy
4,500
+433
+11% +$33K 0.03% 246
2024
Q2 		$279K Sell
4,067
-695
-15% -$46.4K 0.03% 273
2024
Q1 		$349K Buy
4,762
+336
+8% +$25.8K 0.04% 220
2023
Q4 		$359K Buy
4,426
+182
+4% +$14.2K 0.04% 202
2023
Q3 		$318K Sell
4,244
-43
-1% -$3.31K 0.04% 205
2023
Q2 		$330K Buy
4,287
+84
+2% +$6.7K 0.04% 195
2023
Q1 		$349K Buy
4,203
+1,590
+61% +$132K 0.05% 169
2022
Q4 		$224K Buy
+2,613
New +$207K 0.04% 183

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

PDS Planning's GILD Position: Q1 2026 in Review

PDS Planning increased its Gilead Sciences (GILD) stake by 2.8% in Q1 2026, buying an estimated $23.7K and bringing the position to 6,101 shares worth $850K. The position accounts for 0.06% of the portfolio, ranked #168.

PDS Planning first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • PDS Planning held 6,101 shares of Gilead Sciences worth $850K as of Q1 2026.
  • PDS Planning bought 169 Gilead Sciences shares in Q1 2026, an estimated $23.7K.
  • Gilead Sciences made up 0.06% of PDS Planning's portfolio in Q1 2026, its #168 holding.
  • PDS Planning first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on PDS Planning's 13F filing for Q1 2026, filed 22 Apr 2026.